Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078583HIVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009148HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20009386HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS20059821HPVENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TVIS44038999HTLV-1ENSG00000113749.8protein_codingHRH2NoNo3274A0A1B0GTK7
P25021
TCGA Plot Options
Drug Information
GeneHRH2
DrugBank IDDB01142
Drug NameDoxepin
Target IDBE0000112
UniProt IDP25021
Regulation Typeantagonist
PubMed IDs2897127; 2141000
CitationsBeil W, Hannemann H, Sewing KF: Interaction of antidepressants and neuroleptics with histamine stimulated parietal cell adenylate cyclase and H+ secretion. Pharmacology. 1988;36(3):198-203.@@Figueiredo A, Ribeiro CA, Goncalo M, Almeida L, Poiares-Baptista A, Teixeira F: Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol. 1990;4(2):147-58.
GroupsApproved; Investigational
Direct ClassificationDibenzoxepines
SMILES[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12
PathwaysDoxepin Metabolism Pathway; Doxepin H1-Antihistamine Action
PharmGKBPA449409
ChEMBLCHEMBL1628227